Mangoceuticals (MGRX) Gross Margin (2023 - 2026)

Mangoceuticals (MGRX) reported Gross Margin of 42.73% for Q1 2026, down 1405.0% on a YoY basis from 3.27% in Q1 2025, and down 15.06% sequentially from 50.31% in Q4 2025.

Mangoceuticals (MGRX) Gross Margin (2023 - 2026) Analysis & Trends

Mangoceuticals (MGRX) has 4 years of Gross Margin data on file, last reported at 42.73% in Q1 2026.

  • For the quarter ending Q1 2026, Gross Margin fell 1405.0% year-over-year to 42.73%; the trailing twelve-month figure through Mar 2026 stood at 52.42% (down 523.0% YoY), and the FY2025 full-year result was 54.91%, down 679.0% from the prior year.
  • Gross Margin eased to 42.73% in Q1 2026, from 50.31% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 76.11% in Q4 2024 to a low of 42.73% in Q1 2026.
  • A 4-year average of 57.64% and a median of 58.35% in 2023 frame the typical range for Gross Margin.
  • Across the five-year window, Gross Margin surged 1776 bps in 2024 and slumped 2580 bps in 2025, its largest moves.
  • Tracing MGRX's Gross Margin over 4 years: stood at 58.35% in 2023, then jumped by 30 bps to 76.11% in 2024, then tumbled by 34 bps to 50.31% in 2025, then fell by 15 bps to 42.73% in 2026.
  • Business Quant data shows MGRX's Gross Margin at 42.73% in Q1 2026, 50.31% in Q4 2025, and 60.42% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Veeva Systems 31.81 Bn 24.49 Bn 662.02 Mn 74.98%
2 BrightSpring Health Services 14.76 Bn 13.86 Bn 482.22 Mn 13.34%
3 Healthequity 8.36 Bn 8.10 Bn 256.31 Mn 72.27%
4 Hinge Health 5.91 Bn 5.60 Bn 154.23 Mn 84.60%
5 10x Genomics 5.89 Bn 5.35 Bn 106.18 Mn 70.39%
6 MiniMed 4.45 Bn 4.16 Bn 480.00 Mn 57.35%
7 Waystar Holding 4.41 Bn 4.35 Bn 216.84 Mn 69.08%
8 Doximity 3.93 Bn 3.18 Bn 125.97 Mn 86.65%
9 Privia Health 3.10 Bn 2.68 Bn - -
10 Mangoceuticals 9.39 Mn 9.20 Mn 29,001.00 42.73%

Historic Data

Download Data
DateValue
Mar 31, 2026 42.73%
Dec 31, 2025 50.31%
Sep 30, 2025 60.42%
Jun 30, 2025 53.51%
Mar 31, 2025 56.78%
Dec 31, 2024 76.11%
Sep 30, 2024 61.99%
Jun 30, 2024 42.77%
Mar 31, 2024 68.85%
Dec 31, 2023 58.35%
Sep 30, 2023 58.98%
Jun 30, 2023 61.69%
Mar 31, 2023 56.79%